[1]
Channareddy, L.R., Ravula, E.R. and P., V.K.G. 2016. Escitalopram reduces severity of depression and improves quality of life in patients with chronic obstructive pulmonary disease in an open label parallel group study. International Journal of Basic & Clinical Pharmacology. 5, 2 (Dec. 2016), 281–284. DOI:https://doi.org/10.18203/2319-2003.ijbcp20160650.